纵横研报
Ticker Detail

603676.SHG

¥9.3+2.76% 卫信康 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Tibet Weixinkang Medicine Co Ltd
医疗健康 · 专科与仿制药

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins; electrolyte supplements; intravenous iron, trace, electrolytes, and amino acids supplements; antibiotics; acetylcysteine solution for inhalation; medicine for liver diseases; and other special fields. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2002 and is based in Lhasa, China.

MARKET 市值 3.81B CNY PE 17.5x 52W ¥7.82 – ¥13.91 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 8.9% ROE 14.4% 营业利润率 24.0% 净利润率 18.6%
ANALYST 股息率 3.78%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制